Evidence map›Paper›PMID 34885693›Full record

ReviewMolecules (Basel, Switzerland)2021

The Multifaceted Role of Curcumin in Advanced Nanocurcumin Form in the Treatment and Management of Chronic Disorders.

Priti Tagde, Pooja Tagde, Fahadul Islam, Sandeep Tagde, Muddaser Shah, Zareen Delawar Hussain, Md Habibur Rahman, Agnieszka Najda, Ibtesam S Alanazi, Mousa O Germoush and 5 more

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Innovative hyaluronic acid-decorated quatsomes for enhanced renal targeting: design, optimization andJournal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2026
    Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Priti TagdeAmity Institute of Pharmacy, Amity University, Noida 201303, India.ORCID 0000-0002-0375-9165
Pooja TagdePractice of Medicine Department, Government Homeopathy College, Bhopa l462016, India.
Fahadul IslamDepartment of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh.ORCID 0000-0002-8167-8264
Sandeep TagdePRISAL Foundation (Pharmaceutical Royal International Society), Bhopa l462026, India.
Muddaser ShahDepartment of Botany, Abdul Wali Khan University Mardan, Mardan 23200, Pakistan.ORCID 0000-0001-8839-4419
Zareen Delawar HussainIntegro Pharma Ltd., Dhaka 1206, Bangladesh.
Md Habibur RahmanDepartment of Pharmacy, Southeast University, Banani, Dhaka 1213, Bangladesh.ORCID 0000-0001-6099-5693
Agnieszka NajdaDepartment of Vegetable and Herbal Crops, University of Life Sciences in Lublin, 50A Doświadczalna Street, 20-280 Lublin, Poland.ORCID 0000-0002-1185-8884
Ibtesam S AlanaziDepartment of Biology, Faculty of Sciences, University of Hafr Al Batin, Hafr Al Batin 39524, Saudi Arabia.ORCID 0000-0002-5144-9356
Mousa O GermoushBiology Department, College of Science, Jouf University, Sakaka P.O. Box 2014, Saudi Arabia.
Hanan R H MohamedZoology Department, Faculty of Science, Cairo University, Giza 12613, Egypt.ORCID 0000-0002-9457-9054
Mardi M AlgandabyDepartment of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Mohammed Z NasrullahDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0002-4755-0742
Natalia KotDepartment of Landscape Architecture, University of Life Science in Lublin, 28 Gleboka Street, 20-612 Lublin, Poland.
Mohamed M Abdel-DaimPharmacy Program, Department of Pharmaceutical Sciences, Batterjee Medical College, Jeddah 21442, Saudi Arabia.ORCID 0000-0002-4341-2713

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Curcumin is the primary polyphenol in turmeric's curcuminoid class. It has a wide range of therapeutic applications, such as anti-inflammatory, antioxidant, antidiabetic, hepatoprotective, antibacterial, and anticancer effects against various cancers, but has poor solubility and low bioavailability. Objective: To improve curcumin's bioavailability, plasma concentration, and cellular permeability processes. The nanocurcumin approach over curcumin has been proven appropriate for encapsulating or loading curcumin (nanocurcumin) to increase its therapeutic potential. Conclusion: Though incorporating curcumin into nanocurcumin form may be a viable method for overcoming its intrinsic limitations, and there are reasonable concerns regarding its toxicological safety once it enters biological pathways. This review article mainly highlights the therapeutic benefits of nanocurcumin over curcumin.

Indexed as

Anti-Bacterial AgentsAnti-Inflammatory AgentsBiological AvailabilityChronic DiseaseCurcuminHumansNanoparticlesNanotechnologySolubilityAnti-Bacterial AgentsAnti-Inflammatory AgentsCurcuminanticanceranti-inflammatory actionantioxidant effectnanocurcuminneurodegenerative diseasesolubility

Identifiers

PMID34885693
PMCPMC8659038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.